Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.

Featured Stories

DOJ Fraud Division Set To Shake Up White-Collar Enforcement No Photo Available

President Donald Trump's administration created the U.S. Department of Justice's National Fraud Enforcement Division with a narrow foc... (more story)

Trans Care In Court: Gov't Probes, Forum Concerns And More No Photo Available

Law360 Healthcare Authority looks at developments over the past week in legal challenges to probes by the Justice Department and Feder... (more story)

A Battle Bigger Than Abortion Pills On Deck At High Court No Photo Available

The outcome of the latest abortion clash at the high court could reach well beyond mifepristone access and make other federal policy c... (more story)